PPIDT00124
Drug Information
| Name | Afamelanotide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB04931 |
| Type | small molecule |
| Indication | Afamelanotide is indicated for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).[L9086] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Implant | Subcutaneous |
16 MG
|
| Implant | Subcutaneous |
16 mg/16mg
|